Recovery research · Compound identity matters
Look closely at what a repair claim is built on.
TB-500 appears in many recovery and stack discussions, often alongside references to thymosin beta-4. Those names need careful handling. Explore what FDA evaluated in 2026, why different molecular materials should not be treated as interchangeable and where clinical evidence remains insufficient for an available treatment program.
Educational topic · This is not an offered treatment or trial-access program.
Research & evidence
Clear prices. A clearer next step.
Explore the research. Understand the price context.
The research-market figure below is educational context. Neither a free account nor optional membership purchases access to this compound.
Published research-market starting price · not a treatment offer
TB-500 · research market context
Listed from $78per research vial · quantity varies by selected 5 mg or 10 mg variant
Lowest displayed catalog price across the 5 mg and 10 mg variants. The exact price-to-quantity mapping was not independently verified. The seller calls this full-length thymosin beta-4; not all TB-500 labels describe interchangeable material.
Research-material market context only. Seine Bio does not sell lyophilized powders for self-reconstitution or offer this research compound. This figure does not price a finished clinical product; any lawful treatment requires its own quote. Membership does not provide the named investigational compound.
Discuss my care optionsPrice sources & what is included
Public research-material listings reviewed October 7, 2026. Prices and stock can change; taxes and shipping may be additional. These source links document laboratory listings, not patient-use products, supplier quality or lawful clinical availability.
Optional product-savings membership
Start with a personal care conversation.
$20Per month · Cancel anytime
- 2% off products; therapy services and membership dues excluded
- Free two-business-day shipping after dispatch on $100+ physical-product orders before discounts and taxes in the contiguous United States
- Cancel anytime to stop future membership renewals
Medication, labs, products and additional treatment cost extra. Care is subject to clinical fit and availability. Membership does not guarantee a prescription, named peptide or research enrollment.
Create a free account ↗The context behind the conversation
TB-500 Research.
A clearer overview.
Research information is not treatment access.
Research education. No approved TB-500 drug or verified treatment supply is offered.
The biological question.
FDA’s 2026 TB-500 evaluation concerns an acetylated seven-amino-acid fragment. It is not interchangeable with full-length thymosin beta-4 simply because a seller or article uses the names together. Mechanism and study interpretation depend on the actual material. If a claim cites a paper, the first useful question is whether that paper studied the same compound, preparation and route being promoted.
The story behind the name.
TB-500 became a recognizable stack name before a clear approved treatment role was established. Its compounding nomination was withdrawn, and FDA evaluated the substances at the July 2026 advisory meeting on its own initiative. The committee process gives advice, not a binding authorization or finished-drug approval. This page therefore remains an evidence explainer. No later final legal supply route was verified here.
FDA evaluated the nominated TB-500 substances for wound healing. Its briefing did not identify human clinical studies establishing the proposed substances’ effectiveness or safety for the nominated use. It describes material-characterization and quality uncertainties and notes that no applicable USP/NF monograph or approved drug component was identified. Research involving another thymosin-related material cannot fill those gaps automatically. A broader phrase such as “repair peptide” does not identify a clinically demonstrated treatment outcome.
Understand the evidence
Understanding doses
and cycles.
A clear reference for your conversation with a clinician.
Research doses describe a specific study, not a treatment plan. Online popularity does not establish safety.
| Preparation / context | Dose reference | Frequency | Duration / cycle | Evidence & source |
|---|---|---|---|---|
| TB-500 | Not established for this proposed wellness use | Not established | No validated human on/off cycle | Evidence limitations Full-length thymosin beta-4 studies cannot be substituted for a TB-500 fragment. Read the source |
Swipe or scroll sideways to see every column. There is no universal peptide cycle. A published trial, a product label and an informal online protocol are different kinds of information.
Sources reviewed October 7, 2026. A dose listed here does not establish availability or suitability through Seine Bio.
Discuss my optionsA useful conversation includes the limits
Know the concerns.
Understand the criteria.
These are key considerations, not a complete safety assessment.
Risks & uncertainties
What deserves attention.
- FDA identifies potential immune reactions associated with aggregation and peptide-related impurities.
- Human safety and effectiveness information for the evaluated substances is lacking.
- Inconsistent naming can obscure whether a cited study or advertised product refers to the same material.
- A mixed stack adds formulation questions that separate ingredient claims do not resolve.
Clinical & regulatory context
Where this pathway fits.
- No TB-500 prescription or purchase qualification path is offered through this page.
- The exact material must be distinguished from full-length thymosin beta-4.
- Any future program requires current legal verification and an actual licensed care and product route.
- A wound or recovery issue should be evaluated according to its clinical needs.
A thoughtful way forward
Learning is a useful first step.
Begin with your questions.
Read the current FDA evaluation.
Understand the evidence.
Check the compound identity behind any study or online claim.
Clarify your next step.
Discuss an appropriate evaluation and established care options for the actual problem.
Educational topic · This is not an offered treatment or trial-access program.
Create a free account ↗Clear answers before you decide
Your questions.
A clearer starting point.
Take a moment to understand the practical differences, limits and next steps.
Is TB-500 the same as thymosin beta-4?
FDA’s evaluated TB-500 material is an acetylated seven-amino-acid fragment. Full-length thymosin beta-4 is a different material. Seller naming may be inconsistent, so evidence should be matched to the actual compound rather than a broad family name.
Does research show that this heals human injuries?
The cited FDA evaluation did not establish human clinical effectiveness for the proposed TB-500 substances and use. Laboratory or related-compound findings should not be converted into a dependable injury-recovery promise.
Can it be offered because of the 2026 committee meeting?
The advisory process is nonbinding and differs from a final compounding authorization. No later final legal supply route was verified for this page. It is not a treatment enrollment or purchasing page.
How should I approach a recovery stack claim?
Identify each ingredient, the actual finished product and the study behind each claimed outcome. Separate component research is not proof that a mixture works or is safe. A clinical assessment should begin with your condition and appropriate available care.
Your next step, made simple
Bring your questions.
Find your next step.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
- Research questions and established care options
- Clear availability and costs before you decide
- Personal health history shared through private clinical intake
This is a consultation inquiry, not an order for this compound or a request for guaranteed research access. Clinical suitability and any separate costs are confirmed later.
Start with a free account.
Optional membership: $20/month.
Optional · $20/month · Cancel anytime. Medications, labs, products, additional therapy and separately priced treatments cost extra.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
Please keep medical history, medications and sensitive personal details for private clinical intake.
Read beyond the headline
The sources.
Your own closer look.
Follow the original research, prescribing information and official regulatory sources used for this page.
Reviewed October 7, 2026. Evidence and regulatory status can change.
Your next step.Understand your options first.
Create a free accountIndividual care decisions belong to a licensed clinician. Program information does not guarantee a prescription, named compound, appointment, clinical-trial enrollment or product availability. Clinical care requires appropriate licensing, assessment and follow-up. Membership does not replace clinical eligibility.
We do not provide emergency services. For immediate danger or a medical emergency, call 911. For a mental health crisis in the U.S., call or text 988.
Lifestyle imagery is illustrative, not a patient testimonial.